Bank of Montreal
ALNA

Bank of Montreal’s Allena Pharmaceuticals ALNA Stock Holding History

Bank of Montreal’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13
Closed – – 5082
2019
Q2 		$0 Buy
+13
New +$71 ﹤0.01% 5153
2019
Q1 		– Sell
-163
Closed -$1K – 4913
2018
Q4 		$1K Buy
163
+83
+104% +$716 ﹤0.01% 4592
2018
Q3 		$1K Sell
80
-2
-2% -$22 ﹤0.01% 4644
2018
Q2 		$1K Buy
+82
New +$1.18K ﹤0.01% 4635

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bank of Montreal's ALNA Position: Q3 2019 in Review

Bank of Montreal sold out of Allena Pharmaceuticals (ALNA) in Q3 2019, closing a stake of 13 shares.

Bank of Montreal first reported a position in ALNA in Q2 2018 and held it in 4 quarters. The position peaked at $1K in Q4 2018. 35 funds tracked by Wall St. Rank hold ALNA as of Q3 2019.

  • Bank of Montreal reported no remaining Allena Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Bank of Montreal sold 13 Allena Pharmaceuticals shares in Q3 2019.
  • Bank of Montreal first reported a position in Allena Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Bank of Montreal's Allena Pharmaceuticals position peaked at $1K in Q4 2018.
  • 35 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2019.

Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.